Candel Therapeutics Stock Analysis

Candel Stock Analysis Notes

About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.73. Candel Therapeutics had not issued any dividends in recent years. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company was incorporated in 2003 and is based in Needham, Massachusetts. Candel Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 65 people. For more info on Candel Therapeutics please contact FOCIS MD at 617 916 5445 or go to https://www.candeltx.com.

Candel Therapeutics Investment Alerts

Candel Therapeutics Upcoming and Recent Events

Candel Largest EPS Surprises

View All Earnings Estimates

Candel Therapeutics Environmental, Social, and Governance (ESG) Scores

Candel Stock Institutional Investors

Note, although Candel Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Candel Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 134.29 M.

Candel Profitablity

Management Efficiency

Candel Therapeutics has return on total asset (ROA) of (0.5231) % which means that it has lost $0.5231 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.8068) %, meaning that it created substantial loss on money invested by shareholders. Candel Therapeutics' management efficiency ratios could be used to measure how well Candel Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -1.01 this year. The value of Return On Capital Employed is expected to slide to -0.51. At this time, Candel Therapeutics' Asset Turnover is quite stable compared to the past year.

Technical Drivers

As of the 21st of March, Candel Therapeutics shows the Risk Adjusted Performance of 0.0697, mean deviation of 6.07, and Downside Deviation of 9.37. Candel Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Candel Therapeutics maximum drawdown, and the relationship between the information ratio and downside variance to decide if Candel Therapeutics is priced correctly, providing market reflects its regular price of 8.25 per share. Given that Candel Therapeutics has jensen alpha of 0.8494, we suggest you to validate Candel Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.

Candel Therapeutics Price Movement Analysis

Candel Therapeutics Insider Trading Activities

Candel Therapeutics Outstanding Bonds

Candel Therapeutics Predictive Daily Indicators

Candel Therapeutics Corporate Filings

Candel Therapeutics Forecast Models

Candel Therapeutics' time-series forecasting models are one of many Candel Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Candel Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Candel Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Candel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Candel Therapeutics. By using and applying Candel Stock analysis, traders can create a robust methodology for identifying Candel entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Candel analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Candel analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Candel Therapeutics stock analysis indicators help investors evaluate how Candel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Candel Therapeutics shares will generate the highest return on investment. By understating and applying Candel Therapeutics stock analysis, traders can identify Candel Therapeutics position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.